» Authors » Maria Karakosta

Maria Karakosta

Explore the profile of Maria Karakosta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 125
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Konstantinou C, Karakosta M, Venetsanopoulou A, Korantzopoulos P, Voulgari P
Clin Exp Rheumatol . 2024 Oct; 43(3):526-532. PMID: 39436722
Atrial fibrillation (AF) is the most common arrhythmia in clinical practice and it is associated with increased morbidity and mortality. AF is linked with inflammatory signalling while inflammation and oxidative...
2.
Miaris N, Zampelis D, Ntalekou K, Karakosta M, Kalesi A, Kasinos N
Rev Port Cardiol . 2024 Jul; 43(12):725-726. PMID: 38964466
No abstract available.
3.
Memi T, Koletsos N, Gerolymatou N, Karakosta M, Georgiadis A, Drosos A, et al.
Mediterr J Rheumatol . 2024 Jan; 34(4):577-580. PMID: 38282939
Polymyalgia Rheumatica (PMR) and Giant Cell Arteritis (GCA) are chronic inflammatory disorders that usually affect older people. Although the aetiology of these diseases remains unknown, genetic, environmental, and immune factors...
4.
Ntiloudi D, Rammos S, Karakosta M, Kalesi A, Kasinos N, Giannakoulas G
J Clin Med . 2023 Nov; 12(22). PMID: 38002634
With the aging of congenital heart disease (CHD) patients, the burden of arrhythmias is expanding. Atrial arrhythmias, especially intra-atrial reentrant tachycardia and atrial fibrillation, are the most prevalent forms of...
5.
Zachos P, Nevras V, Milaras N, Karakosta M, Kalesi A, Kasinos N, et al.
Heart Fail Rev . 2022 Mar; 28(1):97-112. PMID: 35286572
Tetralogy of Fallot (ToF) is considered to be the most common, complex, cyanotic congenital heart disease (CHD) representing 7-10% of all congenital heart defects, whereas the patients with ToF are...
6.
Miaris N, Kasinos N, Karakosta M, Linardakis S, Maritsa D, Patsourakos N, et al.
Rev Port Cardiol (Engl Ed) . 2021 Aug; 40(8):627-630. PMID: 34392910
No abstract available.
7.
Fergadis E, Assi A, Kranidioti E, Kosma A, Karakosta M, Miltiadous C, et al.
Clin Lymphoma Myeloma Leuk . 2019 Dec; 20(2):e50-e57. PMID: 31884151
Background: An appreciable proportion of patients in need of salvage high-dose chemotherapy (HDC) and autologous peripheral blood stem cell (PBSC) transplantation (PBSCT) fail to mobilize adequate numbers of hematopoietic progenitors,...
8.
Kosmas C, Kranidioti E, Kosma A, Karakosta M, Miltiadous C, Grivas A, et al.
Leuk Lymphoma . 2019 Jan; 60(7):1819-1822. PMID: 30618317
No abstract available.
9.
Ioannidou A, Zachaki S, Karakosta M, Daraki A, Roussou P, Manola K
Cytogenet Genome Res . 2018 Mar; 154(3):126-131. PMID: 29587287
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults and is characterized by the presence of specific cytogenetic abnormalities. CLL research has been focused on epigenetic...
10.
Terzoudi G, Pantelias G, Darroudi F, Barszczewska K, Buraczewska I, Depuydt J, et al.
Int J Radiat Biol . 2016 Nov; 93(1):48-57. PMID: 27813725
Purpose: Dose assessment intercomparisons within the RENEB network were performed for triage biodosimetry analyzing G-lymphocyte PCC for harmonization, standardization and optimization of the PCC assay. Materials And Methods: Comparative analysis...